TRICAST: Announces formation of board of directors

Lynn Lobit

MILWAUKEE, March 15, 2016 /PRNewswire/ — TRICAST is delighted to announce the formation of its inaugural Board of Directors, comprised of industry experts from across the country.

Coming on the heels of last summer’s equity financing partnership with Brook Venture Partners and Blue Heron Capital, the Board is charged with providing guidance and strategic direction of company activities.

Board members include:

-Fred Morris, Chairman of the Board, and Partner at Brook Ventures
-Andrew Tichenor, Partner at Blue Heron Capital
-Colleen Jones, Senior Manager of Billing Compliance at Walmart, and Senior FWA subject matter expert
-Ron Lyons, Assistant Professor and Director of Drug Information at Hampton University, and Principal at Pharmacy Benefit Resources, a healthcare analytics consultancy
Greg Rucinski, President and CEO of TRICAST

“The appointment of our Board underscores the steps we are taking to build the premier company in our market space,” said Greg Rucinski, TRICAST President and CEO. “The Board will provide extensive and applicable experience that will complement the skill of the TRICAST executive team. We are very excited to be working with such a strong leadership group.”


TRICAST leverages its extensive technology and claims processing expertise, client insight and multiple industry experts to offer forward-thinking, full-scope pharmacy benefit oversight solutions. Founded in 1997, TRICAST provides audit and consulting services, and its innovative Reveal™ software, a web-based pharmacy benefit surveillance and analytics package. TRICAST’s expertise and experience enables delivery of comprehensive assessments of pharmacy programs. For more information visit or follow TRICAST on Twitter at @TRICASTINC.

About Brook Venture Partners

Since 1995, Brook Venture Partners has invested in or acquired controlling interest in over 40 expansion stage companies in the Northeastern and Mid-Atlantic US. We are focused on profitable companies in the Information Technology and Healthcare IT sectors, with initial investments typically under $10 million.

About Blue Heron Capital

Blue Heron Capital is an innovative alternative investment group representing a proprietary network of executives, entrepreneurs, high net worth individuals and family offices. Our commitment is to build fruitful and sustainable partnerships between management and our investor network.